trending Market Intelligence /marketintelligence/en/news-insights/trending/cv_aeyols7qtz1wd8idcbq2 content esgSubNav
In This List

NuCana appoints independent nonexecutive director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


NuCana appoints independent nonexecutive director

NuCana PLC added Cyrille Leperlier to its board as an independent nonexecutive director.

Leperlier was most recently a senior scientific adviser for Sanofi's corporate business development and M&A group.

U.K.-based NuCana is a clinical-stage biopharmaceutical company that develops products for treating cancer.